Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

4.87USD
15 Dec 2017
Change (% chg)

$-0.35 (-6.70%)
Prev Close
$5.22
Open
$5.14
Day's High
$5.22
Day's Low
$4.87
Volume
10,647
Avg. Vol
10,474
52-wk High
$8.14
52-wk Low
$2.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
FY 2015 Dec '15 1.59 -0.349
Sep '15 1.07 -0.299
Jun '15 3.43 -0.125
Mar '15 0.00 -0.236
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 1.13 1.58 0.70 0.70
Quarter Ending Mar-18 2 0.70 1.40 0.00 --
Year Ending Dec-17 4 4.84 5.30 4.40 5.95
Year Ending Dec-18 4 1.95 5.00 0.00 0.50
Earnings (per share)
Quarter Ending Dec-17 4 -0.53 -0.46 -0.60 -0.65
Quarter Ending Mar-18 2 -0.52 -0.44 -0.61 --
Year Ending Dec-17 4 -1.95 -1.89 -2.03 -2.45
Year Ending Dec-18 4 -2.13 -2.00 -2.33 -2.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.76 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 18.07 100.68 5.40
Price to Book (MRQ) 1.40 13.50 5.38
Price to Tangible Book (MRQ) 1.40 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 64.29 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 433.86 9.00
Sales (TTM) vs TTM 1 Yr. Ago -0.67 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 14.98 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -112.21 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -261.12 15.24
Operating Margin (TTM) -512.56 -556.66 7.76
Operating Margin - 5 Yr. Avg. -- -279.30 10.75
Pre-Tax Margin (TTM) -506.49 -529.90 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.03 11.17
Net Profit Margin (TTM) -506.49 -531.35 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.21 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 25,315,636 864,680,397
Net Income/Employee (TTM) -820,000 3,332,197 101,718,341
Receivable Turnover (TTM) 3.42 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.07 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -36.00 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -36.04 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.30%
# of Holders: 40
Total Shares Held: 10,702,975
3 Mo. Net Change: 92,192
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 13
# Reduced Positions: 15
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.